Main > PHARMA. > Patent. > Expiration Dates>USA> > Year 2016 > Onco.>Lung Cancer>Gefitinib.HCl

Product UK. A

MARKETING Approval in
- Australia
- Canada
- Japan &
- USA
INDICATION'S This data is not available for free
MECHANISM OF ACTION EGFR-TK Inhibition
COMPANY This data is not available for free
PATENT NUMBER This data is not available for free
TRADEMARK This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back